Genesis MedTech Announces the Sale of JC Medical, Inc to Edwards Lifesciences

August 19, 2024 10:00 AM AEST | By Cision

Google News:

Genesis MedTech Announces the Sale of JC Medical, Inc to Edwards Lifesciences — Image source: Kalkine Media

Recent News

Top Entertainment Options in Oahu, Honolulu, Waikiki: What Travelers N...

SYDNEY BASED CBD INSIGHTS LIFESTYLE MAGAZINE COMMENCE FEATURES ON CARP...

At London Climate Week, forestry companies launch Natural Capital Valu...

Apple internally weighs bid for ChatGPT rival Perplexity, Bloomberg sa...

SINGAPORE, Aug. 19, 2024 /PRNewswire/ -- Genesis MedTech has sold JC Medical, Inc. to Edwards Lifesciences, including the intellectual property and commercial rights of its J-Valve® System, a transcatheter aortic valve replacement for the treatment of severe aortic regurgitation. The transaction includes an upfront payment plus potential sales-based contingent milestones.

Genesis MedTech has maintained the exclusive right to develop, manufacture and commercialize the J-Valve® Systemin in Greater China. In July 2023, Genesis MedTech successfully completed patient enrollment for clinical study of J-Valve transfemoral system for the treatment of aortic regurgitation (referred to as J-Valve® TF) in China, and recently concluded the one-year patient follow-up.

In August 2023, JC Medical's J-Valve® TF was granted the "Breakthrough Device Designation" by the U.S. Food and Drug Administration (FDA). JC Medical completed enrollment in its early feasibility study (EFS) of J-Valve® TF in the United States in February 2024. Approval from FDA for JC Medical to initiate its pivotal clinical trial of J-Valve® TF was received in the first half of 2024.

Additionally, Edwards has made an equity investment of $25 million in Genesis MedTech. This investment will support Genesis MedTech's product and market development efforts, showcasing the recognition of Genesis MedTech's product development capabilities and operational model by a global MedTech leader.

"J-VALVE® has unique advantages in treating aortic valve regurgitation." said Warren Wang, Chairman and CEO of Genesis MedTech Group. "We hope that J-Valve® can expand its global impact, enabling more patients to benefit from this innovative product. We will continue strengthening our focus on developing innovative products and explore better medical solutions to benefit more patients worldwide."

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.